ArticleResearch square2026
Breast Cancer Liver Metastasis: Primary tumor predictors and histopathologic characteristics of metastatic lesions.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Young breast cancer patients have increased risk for liver metastasis (BCLM), implicating age-dependent organotropism. To explore potential risk factors and mechanisms of BCLM, we unbiasedly recruited 47 patients diagnosed with BCLM at a tertiary medical center, collected clinicopathologic data of the primary breast cancers, and obtained paired BCLM lesion tissue. Compared to the overall breast cancer patient population, our BCLM cohort was enriched ~4 fold for young patients (YOBC) and ~5 fold for patients diagnosed within 10 years of recent childbirth. The majority of primary breast cancer diagnoses were luminal A, low-grade and early-stage disease, clinical attributes classically associated with good prognosis. Most BCLM lesions were also ER-positive, and the dominant breast cancer growth pattern was replacement. Immunohistology staining infers utilization of existing liver sinusoids, consistent with a passive mechanism of metastatic invasion. In sum, these data suggest that the liver readily supports metastatic establishment of early-stage, luminal A breast cancer cells. These data also support a growing body of literature linking postpartum liver biology to increased risk for BCLM, providing potential insight into the observed age-dependent organotropism of BCLM. Improved understanding of reproductive risk factors for BCLM may improve patient risk stratification and outcomes overall.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.